Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.435
-0.026 (-5.72%)
At close: Jul 19, 2024, 4:00 PM
0.432
-0.003 (-0.69%)
Pre-market: Jul 22, 2024, 9:01 AM EDT
Ensysce Biosciences Employees
Ensysce Biosciences had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,649,517
Market Cap
3.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xylo Technologies | 84 |
| Aditxt | 47 |
| Aptevo Therapeutics | 40 |
| Healthcare Triangle | 31 |
| ZyVersa Therapeutics | 7 |
| Qualigen Therapeutics | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| Avenue Therapeutics | 3 |
ENSC News
- 13 days ago - Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset - Accesswire
- 25 days ago - Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting - Accesswire
- 27 days ago - Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate - Accesswire
- 6 weeks ago - Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program - Accesswire
- 7 weeks ago - Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting - Accesswire
- 2 months ago - Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform - Accesswire
- 2 months ago - Ensysce Biosciences Reports First Quarter 2024 Financial Results - Accesswire
- 3 months ago - Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine - Accesswire